Literature DB >> 28827474

P2y12 Receptor Promotes Pressure Overload-Induced Cardiac Remodeling via Platelet-Driven Inflammation in Mice.

Lujin Wu1, Fujie Zhao1, Meiyan Dai1, Huaping Li1, Chen Chen1, Jiali Nie1, Peihua Wang1, Dao Wen Wang2.   

Abstract

Inflammation plays a critical role in adverse cardiac remodeling and heart failure. The P2y12 receptor is one of the predominant activating receptors for platelets, thus initiating inflammatory responses under various diseases. In this study, we investigated the functional significance of P2y12-mediated platelet activation in pressure overload-induced cardiac remodeling. Notably, P2y12 knockout (P2y12-/-) mice exhibited suppressed transverse aortic constriction-induced changes in cardiac hypertrophy, collagen synthesis, inflammatory cell recruitment, and cardiac dysfunction. Activated platelets and platelet-leukocyte aggregates were markedly downregulated in P2y12 knockout mice compared with wild-type counterparts after transverse aortic constriction. Moreover, bone marrow chimera experiments revealed that wild-type recipients of P2y12 knockout bone marrow markedly improved cardiac function and attenuated cardiac remodeling, reversed by wild-type platelets reinjection. Platelet depletion and P-selectin inhibition mimicked these protective effects by limiting the interaction between activated platelets and leukocytes. Furthermore, activated wild-type platelets directly induced cardiomyocyte hypertrophy and collagen synthesis via α-granule exocytosis, vanished in P2y12 knockout platelets or those administered anti-NSF (N-ethlymalimide-sensitive factor) antibodies. The results suggest that P2y12-mediated platelet activation promotes cardiac remodeling by triggering a series of inflammatory changes and interacting with leukocytes and endotheliocytes.
© 2017 American Heart Association, Inc.

Entities:  

Keywords:  bone marrow; chimera; inflammation; leukocytes; platelet activation

Mesh:

Substances:

Year:  2017        PMID: 28827474     DOI: 10.1161/HYPERTENSIONAHA.117.09262

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  15 in total

Review 1.  The Role of B Cells in Cardiomyopathy and Heart Failure.

Authors:  Kevin Bermea; Aashik Bhalodia; Angelo Huff; Sylvie Rousseau; Luigi Adamo
Journal:  Curr Cardiol Rep       Date:  2022-06-11       Impact factor: 3.955

Review 2.  Insights Into Platelet-Derived MicroRNAs in Cardiovascular and Oncologic Diseases: Potential Predictor and Therapeutic Target.

Authors:  Qianru Leng; Jie Ding; Meiyan Dai; Lei Liu; Qing Fang; Dao Wen Wang; Lujin Wu; Yan Wang
Journal:  Front Cardiovasc Med       Date:  2022-06-09

3.  Give a Leg Up: Screening for Peripheral Artery Disease after Acute Myocardial Infarction.

Authors:  Yasutomi Higashikuni; Wenhao Liu; Masataka Sata
Journal:  J Atheroscler Thromb       Date:  2021-12-01       Impact factor: 4.394

4.  Si-Miao-Yong-An Decoction Protects Against Cardiac Hypertrophy and Dysfunction by Inhibiting Platelet Aggregation and Activation.

Authors:  Congping Su; Qing Wang; Huimin Zhang; Wenchao Jiao; Hui Luo; Lin Li; Xiangyang Chen; Bin Liu; Xue Yu; Sen Li; Wei Wang; Shuzhen Guo
Journal:  Front Pharmacol       Date:  2019-09-18       Impact factor: 5.810

Review 5.  Focus on Autoimmune Myocarditis in Graves' Disease: A Case-Based Review.

Authors:  Lujin Wu; Wei Wang; Qianru Leng; Nana Tang; Ning Zhou; Yan Wang; Dao Wen Wang
Journal:  Front Cardiovasc Med       Date:  2021-07-07

6.  Inhibition of profibrotic microRNA-21 affects platelets and their releasate.

Authors:  Temo Barwari; Seda Eminaga; Ursula Mayr; Ruifang Lu; Paul C Armstrong; Melissa V Chan; Mahnaz Sahraei; Marta Fernández-Fuertes; Thomas Moreau; Javier Barallobre-Barreiro; Marc Lynch; Xiaoke Yin; Christian Schulte; Ferheen Baig; Raimund Pechlaner; Sarah R Langley; Anna Zampetaki; Peter Santer; Martin Weger; Roberto Plasenzotti; Markus Schosserer; Johannes Grillari; Stefan Kiechl; Johann Willeit; Ajay M Shah; Cedric Ghevaert; Timothy D Warner; Carlos Fernández-Hernando; Yajaira Suárez; Manuel Mayr
Journal:  JCI Insight       Date:  2018-11-02

Review 7.  The Platelet Response to Tissue Injury.

Authors:  Felix Eisinger; Johannes Patzelt; Harald F Langer
Journal:  Front Med (Lausanne)       Date:  2018-11-13

8.  Inhibition of Platelets by Clopidogrel Suppressed Ang II-Induced Vascular Inflammation, Oxidative Stress, and Remodeling.

Authors:  Xiangbo An; Guinan Jiang; Cheng Cheng; Zhengshuai Lv; Yang Liu; Feng Wang
Journal:  J Am Heart Assoc       Date:  2018-11-06       Impact factor: 5.501

9.  PPARα ligand, AVE8134, and cyclooxygenase inhibitor therapy synergistically suppress lung cancer growth and metastasis.

Authors:  Lujin Wu; Wei Wang; Meiyan Dai; Huihui Li; Chen Chen; Daowen Wang
Journal:  BMC Cancer       Date:  2019-12-02       Impact factor: 4.430

10.  Cangrelor ameliorates CLP-induced pulmonary injury in sepsis by inhibiting GPR17.

Authors:  Qiancheng Luo; Rui Liu; Kaili Qu; Guorong Liu; Min Hang; Guo Chen; Lei Xu; Qinqin Jin; Dongfeng Guo; Qi Kang
Journal:  Eur J Med Res       Date:  2021-07-06       Impact factor: 2.175

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.